Revance(RVNC) - 2023 Q1 - Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Jessica Serra – Investor Relations Mark Foley – Chief Executive Officer Dustin Sjuts – President Toby Schilke – Chief Financial Officer Conference Call Participants Seamus Fernandez – Guggenheim Balaji Prasad – Barclays Chris Shibutani – Goldman Sachs Stacy Ku – Cowen David Amsellem – Piper Sandler Terence Flynn – Morgan Stanley Operator Welcome to the Revance Therapeutics First Quarter 2023 ...